You are here

Kaleo

Kaléo Inc. Agrees to Pay $12.7 Million to Resolve Allegations of False Claims for Anti-Overdose Drug

DOJ

Wed, 11/10/21 - 09:53 pm

False Claims Act

Health Canada to keep importing Kaleo's epinephrine shot amid shortages

Yahoo/Reuters

Sat, 07/20/19 - 08:28 pm

epinephrine auto-injector

Rival accuses Kaleo of cybersquatting in 'elaborate scheme'

Biopharma Dive

Wed, 07/3/19 - 12:02 am

Adamis Pharmaceuticals

Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

Stat

Wed, 12/12/18 - 09:56 am

opioid addiction

opioid overdose

A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered

Stat

Mon, 11/19/18 - 04:38 pm

opioid addiction

With EpiPen competitors bearing down, can Mylan maintain its lead?

Fierce Pharma

Tue, 09/18/18 - 04:30 pm

ephinephrine autoinjectors

Kaleo partners with Walgreens to offer epinephrine auto-injector

Drug Delivery Business News

Fri, 09/7/18 - 11:08 am

epinephrine auto-injector

In midst of Epipen shortage, Kaleo confirms ‘sufficient supply’ of Auvi-Q auto-injectors

Drug Delivery Business News

Tue, 08/14/18 - 11:56 am

Donations of $4,500 overdose antidote were PR gold for drug maker — but some kits were close to expiring

Stat

Mon, 06/18/18 - 09:54 am

Kaleo launches program to give Auvi-Q allergy devices to schools

Drug Delivery Business News

Mon, 08/7/17 - 10:02 pm

Kaleo fires back at Express Scripts, claiming it’s owed at least $5.3 million

Fierce Pharma

Fri, 06/30/17 - 10:40 am

Express Scripts

Who stands to benefit from Mylan's EpiPen recall?

BioPharma Dive

Thu, 03/23/17 - 09:52 pm

Adamis Pharmaceuticals

After blitzing Mylan, Klobuchar targets Kaléo's pricey Auvi-Q, 700% jack-up on opioid antidote

Fierce Pharma

Mon, 02/6/17 - 11:50 am

Kaléo Pharma’s EpiPen Alternative Launched with Expensive List Price

Xtalks

Mon, 01/30/17 - 11:47 am

EpiPen rivals inch towards market

BioPharma Dive

Sun, 01/22/17 - 01:41 pm

Adamis Pharmaceuticals

EpiPen competitor Auvi-Q comes back Feb. 14 with a pricing scheme that will blow your mind

CNBC

Thu, 01/19/17 - 11:28 pm

EpiPen rival Auvi-Q will return to market next year

Thu, 10/27/16 - 04:04 pm

EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients

Forbes

Wed, 10/26/16 - 09:30 am

Challengers eye a piece of EpiPen market as pricing scandal engulfs Mylan

Fierce Pharma

Tue, 08/30/16 - 10:02 am

Imprimis Pharmaceuticals

Kaleo’s Evzio gets US FDA approval for treatment of opioid overdose

Pharmabiz

Sat, 04/5/14 - 11:53 am